Patents by Inventor Paul Willis Johns

Paul Willis Johns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ellagic acid formulations for use in coagulation assays
    Patent number: 10746749
    Abstract: The present invention relates to ellagic acid formulations for performing coagulation assays that are highly stable for long term storage and reduce assay time. Particularly, aspects of the present invention are directed to a composition and method of preparing ellagic acid in a highly soluble format for use in a coagulation assay. For example, the ellagic acid may be solubilized in one or more of sodium hydroxide, methanol, a polyether compound, particularly polyethylene glycol, polyethylene oxide, or polyoxyethylene, and a cyclodextrin guest-host complex.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: August 18, 2020
    Assignee: Abbott Point of Care Inc.
    Inventors: Gordon Bruce Collier, Paul Willis Johns, Smitha R K Sutrala, Dan Wang, Katrina Petronilla Di Tullio
  • ELLAGIC ACID FORMULATIONS FOR USE IN COAGULATION ASSAYS
    Publication number: 20180196072
    Abstract: The present invention relates to ellagic acid formulations for performing coagulation assays that are highly stable for long term storage and reduce assay time. Particularly, aspects of the present invention are directed to a composition and method of preparing ellagic acid in a highly soluble format for use in a coagulation assay. For example, the ellagic acid may be solubilized in one or more of sodium hydroxide, methanol, a polyether compound, particularly polyethylene glycol, polyethylene oxide, or polyoxyethylene, and a cyclodextrin guest-host complex.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Applicant: Abbott Point of Care Inc.
    Inventors: Gordon Bruce Collier, Paul Willis Johns, Smitha RK Sutrala, Dan Wang, Katrina Petronilla Di Tullio
  • Ellagic acid formulations for use in coagulation assays
    Patent number: 9921232
    Abstract: The present invention relates to ellagic acid formulations for performing coagulation assays that are highly stable for long term storage and reduce assay time. Particularly, aspects of the present invention are directed to a composition and method of preparing ellagic acid in a highly soluble format for use in a coagulation assay. For example, the ellagic acid may be solubilized in one or more of sodium hydroxide, methanol, a polyether compound, particularly polyethylene glycol, polyethylene oxide, or polyoxyethylene, and a cyclodextrin guest-host complex.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: March 20, 2018
    Assignee: Abbott Point of Care Inc.
    Inventors: Gordon Bruce Collier, Paul Willis Johns, Jr., Smitha R K Sutrala, Dan Wang, Katrina Petronilla Di Tullio
  • ELLAGIC ACID FORMULATIONS FOR USE IN COAGULATION ASSAYS
    Publication number: 20160091512
    Abstract: The present invention relates to ellagic acid formulations for performing coagulation assays that are highly stable for long term storage and reduce assay time. Particularly, aspects of the present invention are directed to a composition and method of preparing ellagic acid in a highly soluble format for use in a coagulation assay. For example, the ellagic acid may be solubilized in one or more of sodium hydroxide, methanol, a polyether compound, particularly polyethylene glycol, polyethylene oxide, or polyoxyethylene, and a cyclodextrin guest-host complex.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 31, 2016
    Inventors: Gordon Bruce Collier, Paul Willis Johns, JR., Smitha RK Sutrala, Dan Wang, Katrina Petronilla Di Tullio